Showing 1 - 11 results of 11 for search 'Torsten Tonn', query time: 0.03s
Refine Results
-
1
Editorial: Translating NK cell scientific research to clinical product manufacturing by Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, Volker Huppert, Torsten Tonn, Wing Leung
Published 2023-08-01
Article -
2
Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer by Nivedha Murali Shankar, Nivedha Murali Shankar, Nivedha Murali Shankar, Nivedha Murali Shankar, Paola Ortiz-Montero, Paola Ortiz-Montero, Anastasia Kurzyukova, Anastasia Kurzyukova, Wiebke Rackwitz, Wiebke Rackwitz, Stephan R. Künzel, Stephan R. Künzel, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels, Torsten Tonn, Torsten Tonn, Torsten Tonn, Franziska Knopf, Franziska Knopf, Jiri Eitler, Jiri Eitler
Published 2023-10-01
Article -
3
NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme by Shafiq Murad, Susanne Michen, Alexander Becker, Monika Füssel, Gabriele Schackert, Torsten Tonn, Frank Momburg, Achim Temme
Published 2022-05-01
Article -
4
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo by Renata Nacasaki Silvestre, Jiri Eitler, Jiri Eitler, Julia Teixeira Cottas de Azevedo, Mariane Cariati Tirapelle, Daianne Maciely Carvalho Fantacini, Lucas Eduardo Botelho de Souza, Kamilla Swiech, Dimas Tadeu Covas, Rodrigo T. Calado, Paola Ortiz Montero, Paola Ortiz Montero, Kelen Cristina Ribeiro Malmegrim, Kelen Cristina Ribeiro Malmegrim, Marxa L. Figueiredo, Torsten Tonn, Torsten Tonn, Torsten Tonn, Virginia Picanço-Castro
Published 2023-09-01
Article -
5
442-Q CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation by Torsten Tonn, Winfried Wels, Hans Klingemann, Jiri Eitler, Natalie Wotschel, Laurent Boissel, Paola Ortiz Montero, Wiebke Rackwitz, Venugopal Gudipati, Johannes Huppa
Published 2023-11-01Article -
6
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer by David Digomann, Max Heiduk, Charlotte Reiche, Jessica Glück, Christoph Kahlert, Peter Mirtschink, Anna Klimova, Florian Bösch, Torsten Tonn, Jochen Gaedcke, Michael Ghadimi, Jürgen Weitz, Lena Seifert, Adrian M. Seifert
Published 2023-10-01
Article -
7
OECD workshop consensus report: Ethical considerations with respect to human derived products, specifically human serum, in OECD test guidelines by Miriam N. Jacobs, Jan M. Bult, Kevin Cavanagh, Christophe Chesne, Nathalie Delrue, Jianan Fu, Emma Grange, Ingrid Langezaal, Dominika Misztela, Jenny Murray, Martin Paparella, Gilly Stoddart, Torsten Tonn, Carol Treasure, Masaaki Tsukano, Rosemary Versteegen
Published 2023-02-01
Article -
8
Perturbations of mesenchymal stromal cells after allogeneic hematopoietic cell transplantation predispose for bone marrow graft-versus-host-disease by Thomas Krüger, Thomas Krüger, Rebekka Wehner, Rebekka Wehner, Rebekka Wehner, Maik Herbig, Maik Herbig, Maik Herbig, Martin Kräter, Martin Kräter, Michael Kramer, Jan Moritz Middeke, Friedrich Stölzel, Catrin List, Katharina Egger-Heidrich, Raphael Teipel, Uta Oelschlägel, Martin Wermke, Martin Wermke, Helena Jambor, Manja Wobus, Johannes Schetelig, Korinna Jöhrens, Torsten Tonn, Torsten Tonn, Julien Subburayalu, Julien Subburayalu, Julien Subburayalu, Julien Subburayalu, Marc Schmitz, Marc Schmitz, Marc Schmitz, Marc Schmitz, Martin Bornhauser, Martin Bornhauser, Martin Bornhauser, Martin Bornhauser, Malte von Bonin, Malte von Bonin
Published 2022-10-01
Article -
9
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation by Torsten Tonn, Hans Klingemann, Winfried S Wels, Jiri Eitler, Natalie Wotschel, Laurent Boissel, Michael Bachmann, Wiebke Rackwitz, Venugopal Gudipati, Nivedha Murali Shankar, Anastasia Sidorenkova, Johannes B Huppa, Paola Ortiz-Montero, Corinna Opitz, Stephan R Künzel, Susanne Michen, Achim Temme, Liliana Rodrigues Loureiro, Anja Feldmann
Published 2024-02-01
Article -
10
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma by Catrin Heim, Laura M. Moser, Laura M. Moser, Laura M. Moser, Laura M. Moser, Herman Kreyenberg, Halvard B. Bonig, Halvard B. Bonig, Torsten Tonn, Torsten Tonn, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels, Elise Gradhand, Elise Gradhand, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, Michael T. Meister, Michael T. Meister, Marian Groot Koerkamp, Marian Groot Koerkamp, Frank C. P. Holstege, Frank C. P. Holstege, Jarno Drost, Jarno Drost, Jan-Henning Klusmann, Jan-Henning Klusmann, Jan-Henning Klusmann, Jan-Henning Klusmann, Peter Bader, Peter Bader, Michael Merker, Michael Merker, Eva Rettinger, Eva Rettinger, Eva Rettinger, Eva Rettinger
Published 2023-08-01
Article -
11
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients by Sixten Körper, Beate Grüner, Daniel Zickler, Thomas Wiesmann, Patrick Wuchter, Rainer Blasczyk, Kai Zacharowski, Peter Spieth, Torsten Tonn, Peter Rosenberger, Gregor Paul, Jan Pilch, Joachim Schwäble, Tamam Bakchoul, Thomas Thiele, Julian Knörlein, Matthias M. Dollinger, Jörg Krebs, Martin Bentz, Victor M. Corman, Dzenan Kilalic, Gerlinde Schmidtke-Schrezenmeier, Philipp M. Lepper, Lucas Ernst, Hinnerk Wulf, Alexandra Ulrich, Manfred Weiss, Jan Matthias Kruse, Thomas Burkhardt, Rebecca Müller, Harald Klüter, Michael Schmidt, Bernd Jahrsdörfer, Ramin Lotfi, Markus Rojewski, Thomas Appl, Benjamin Mayer, Philipp Schnecko, Erhard Seifried, Hubert Schrezenmeier
Published 2022-12-01
Article